Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Prices
Marketing
Coherus prices China-made PD-1 at 20% discount to Keytruda
The U.S. price of the first PD-1 inhibitor developed in China has been revealed, and it's 20% cheaper than Merck's market-leading Keytruda.
Angus Liu
Nov 27, 2023 6:10pm
CEOs of J&J, Merck, BMS called to testify on drug prices
Nov 21, 2023 3:02pm
FTC takes patent scrutiny to Sanofi, Mylan's insulin case
Nov 21, 2023 11:34am
Pharma industry reaches 'landmark' drug spending deal with UK
Nov 20, 2023 11:00am
Stelara biosim could help J&J elude Medicare price negotiations
Nov 7, 2023 9:45am
NICE rejects cost effectiveness of Vertex's cystic fibrosis meds
Nov 6, 2023 2:42pm
